AI-generated summary
The authors evaluated platelet-rich plasma (PRP) and a 1550 nm fractional erbium-glass laser, alone or combined, in 60 patients with androgenetic alopecia. They report that all patients improved, with greater hair density gains in the combination group, and describe the treatments as safe with no side effects. The abstract does not report the study design or control group.
- Participants
- 60
- Who or what was studied
- Patients with androgenetic alopecia (men and women)
- Wavelengths
- 1550 nm
- Limits stated in the abstract
- The abstract does not describe the study design, control group, or measurement methods, so the strength of the evidence cannot be judged from it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jddonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1550 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia, Laser, Digital object identifier, Photobiomodulation, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.